Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Prothena Corp Public Ltd Co

NASDAQ: PRTA · Life Sciences · 11 alerts · CIK 1559053

Share price
$7.97Close, Nov 16
Market cap
$409M
Shares outstanding
51.35MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Prothena Corp Public Ltd Co filings on SEC EDGAR ↗

4:04 PM ET 8-K
Deal Termination

Prothena Corp Public Ltd Deal Termination with Bristol Myers Squibb

Bristol Myers Squibb (BMS) has terminated its exclusive global license agreement for PRX019 with Prothena following an internal strategic review. As a result of the termination, effective January 28, 2027, Prothena is no longer eligible to receive up to $617.5 million in potential development, regulatory, and sales milestones. BMS will continue to develop moponetug (PRX005) under a separate ongoing collaboration agreement.

Counterparty
Bristol Myers Squibb

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.